Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1084109

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1084109

Global Cough Hypersensitivity Syndrome Market Size study, By Drug Class, Route of Administration, End-Users, Distribution Channel, and Regional Forecasts 2022-2028

PUBLISHED:
PAGES:
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

Global Cough Hypersensitivity Syndrome Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Cough hypersensitivity syndrome (CHS) is a clinical syndrome which causes troublesome coughing. Cough hypersensitivity syndrome triggers due to asthma, postnasal drip, reflux disease, and allergic factors among others. Increasing incidences of chronic respiratory diseases and growing healthcare sector in emerging economies as well as rising trend towards sedentary lifestyle are key drivers for growth of Cough Hypersensitivity Syndrome Market. For instance, according to World Health Organization (WHO)- Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death globally. During 2019, globally 3.23 million people succumbs to COPD. Furthermore, as per The Office of Disease Prevention and Health Promotion (ODPHP) - As of 2020, in USA around 25 million people have asthma and around 14.8 million adults have been diagnosed with COPD. Moreover, annual health care expenditures for asthma disease were estimated at USD 20.7 billion. Also, surging geriatric population and increasing number of clinical trials are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, high treatment cost of Cough Hypersensitivity Syndrome impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Cough Hypersensitivity Syndrome Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing prevalence of respiratory disorders and surging healthcare expenditure as well as presence of leading market players in the region. Whereas, North America is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as rising geriatric population and increasing investment towards healthcare infrastructure development in the region, would create lucrative growth prospects for the Cough Hypersensitivity Syndrome Market across the Asia Pacific region.

Major market players included in this report are:

Akorn, Incorporated (US)

Pfizer Inc. (U.S.)

GlaxoSmithKline plc (U.K.)

Novartis AG (Switzerland)

Mylan N.V. (U.S.)

Teva Pharmaceutical Industries Ltd.(Israel)

Sanofi (France)

Boehringer Ingelheim International GmbH. (Germany)

AstraZeneca (U.K.)

Johnson & Johnson Private Limited (U.S.)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class

Inhales Corticosteroids

Antitussive Agents

Short-acting Beta-2 Agonists

Anticholinergics

Proton Pump Inhibitors

Antihistamines

Others

By Route of Administration

Oral

Inhalation

Others

By End-Users

Hospitals

Specialty Clinics

Homecare

Others

By Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Cough Hypersensitivity Syndrome Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Global Cough Hypersensitivity Syndrome Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Global Cough Hypersensitivity Syndrome Market, by Drug Class, 2020-2028 (USD Million)
    • 1.2.3. Global Cough Hypersensitivity Syndrome Market, by Route of Administration, 2020-2028 (USD Million)
    • 1.2.4. Global Cough Hypersensitivity Syndrome Market, by End Users, 2020-2028 (USD Million)
    • 1.2.5. Global Cough Hypersensitivity Syndrome Market, by Distribution Channel, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Cough Hypersensitivity Syndrome Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Cough Hypersensitivity Syndrome Market Dynamics

  • 3.1. Cough Hypersensitivity Syndrome Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidences of chronic respiratory diseases.
      • 3.1.1.2. Growing healthcare sector in emerging economies.
      • 3.1.1.3. Rising trend towards sedentary lifestyle.
    • 3.1.2. Market Challenges
      • 3.1.2.1. High treatment cost of Cough Hypersensitivity Syndrome.
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Surging geriatric population
      • 3.1.3.2. Increasing number of clinical trials.

Chapter 4. Global Cough Hypersensitivity Syndrome Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Cough Hypersensitivity Syndrome Market, by Drug Class

  • 6.1. Market Snapshot
  • 6.2. Global Cough Hypersensitivity Syndrome Market by Drug Class, Performance - Potential Analysis
  • 6.3. Global Cough Hypersensitivity Syndrome Market Estimates & Forecasts by Drug Class 2018-2028 (USD Million)
  • 6.4. Cough Hypersensitivity Syndrome Market, Sub Segment Analysis
    • 6.4.1. Inhales Corticosteroids
    • 6.4.2. Antitussive Agents
    • 6.4.3. Short-acting Beta-2 Agonists
    • 6.4.4. Anticholinergics
    • 6.4.5. Proton Pump Inhibitors
    • 6.4.6. Antihistamines
    • 6.4.7. Others

Chapter 7. Global Cough Hypersensitivity Syndrome Market, by Route of Administration

  • 7.1. Market Snapshot
  • 7.2. Global Cough Hypersensitivity Syndrome Market by Route of Administration, Performance - Potential Analysis
  • 7.3. Global Cough Hypersensitivity Syndrome Market Estimates & Forecasts by Route of Administration 2018-2028 (USD Million)
  • 7.4. Cough Hypersensitivity Syndrome Market, Sub Segment Analysis
    • 7.4.1. Oral
    • 7.4.2. Inhalation
    • 7.4.3. Others

Chapter 8. Global Cough Hypersensitivity Syndrome Market, by End Users

  • 8.1. Market Snapshot
  • 8.2. Global Cough Hypersensitivity Syndrome Market by End Users, Performance - Potential Analysis
  • 8.3. Global Cough Hypersensitivity Syndrome Market Estimates & Forecasts by End Users 2018-2028 (USD Million)
  • 8.4. Cough Hypersensitivity Syndrome Market, Sub Segment Analysis
    • 8.4.1. Hospitals
    • 8.4.2. Specialty Clinics
    • 8.4.3. Homecare
    • 8.4.4. Others

Chapter 9. Global Cough Hypersensitivity Syndrome Market, by Distribution Channel

  • 9.1. Market Snapshot
  • 9.2. Global Cough Hypersensitivity Syndrome Market by Distribution Channel, Performance - Potential Analysis
  • 9.3. Global Cough Hypersensitivity Syndrome Market Estimates & Forecasts by Distribution Channel 2018-2028 (USD Million)
  • 9.4. Cough Hypersensitivity Syndrome Market, Sub Segment Analysis
    • 9.4.1. Hospital Pharmacy
    • 9.4.2. Retail Pharmacy
    • 9.4.3. Online Pharmacy
    • 9.4.4. Others

Chapter 10. Global Cough Hypersensitivity Syndrome Market, Regional Analysis

  • 10.1. Cough Hypersensitivity Syndrome Market, Regional Market Snapshot
  • 10.2. North America Cough Hypersensitivity Syndrome Market
    • 10.2.1. U.S. Cough Hypersensitivity Syndrome Market
      • 10.2.1.1. Drug Class estimates & forecasts, 2018-2028
      • 10.2.1.2. Route of Administration estimates & forecasts, 2018-2028
      • 10.2.1.3. End Users estimates & forecasts, 2018-2028
      • 10.2.1.4. Distribution Channel estimates & forecasts, 2018-2028
    • 10.2.2. Canada Cough Hypersensitivity Syndrome Market
  • 10.3. Europe Cough Hypersensitivity Syndrome Market Snapshot
    • 10.3.1. U.K. Cough Hypersensitivity Syndrome Market
    • 10.3.2. Germany Cough Hypersensitivity Syndrome Market
    • 10.3.3. France Cough Hypersensitivity Syndrome Market
    • 10.3.4. Spain Cough Hypersensitivity Syndrome Market
    • 10.3.5. Italy Cough Hypersensitivity Syndrome Market
    • 10.3.6. Rest of Europe Cough Hypersensitivity Syndrome Market
  • 10.4. Asia-Pacific Cough Hypersensitivity Syndrome Market Snapshot
    • 10.4.1. China Cough Hypersensitivity Syndrome Market
    • 10.4.2. India Cough Hypersensitivity Syndrome Market
    • 10.4.3. Japan Cough Hypersensitivity Syndrome Market
    • 10.4.4. Australia Cough Hypersensitivity Syndrome Market
    • 10.4.5. South Korea Cough Hypersensitivity Syndrome Market
    • 10.4.6. Rest of Asia Pacific Cough Hypersensitivity Syndrome Market
  • 10.5. Latin America Cough Hypersensitivity Syndrome Market Snapshot
    • 10.5.1. Brazil Cough Hypersensitivity Syndrome Market
    • 10.5.2. Mexico Cough Hypersensitivity Syndrome Market
  • 10.6. Rest of The World Cough Hypersensitivity Syndrome Market

Chapter 11. Competitive Intelligence

  • 11.1. Top Market Strategies
  • 11.2. Company Profiles
    • 11.2.1. Akorn Incorporated (USA)
      • 11.2.1.1. Key Information
      • 11.2.1.2. Overview
      • 11.2.1.3. Financial (Subject to Data Availability)
      • 11.2.1.4. Product Summary
      • 11.2.1.5. Recent Developments
    • 11.2.2. Pfizer Inc. (U.S.)
    • 11.2.3. GlaxoSmithKline plc (U.K.)
    • 11.2.4. Novartis AG (Switzerland)
    • 11.2.5. Mylan N.V. (U.S.)
    • 11.2.6. Teva Pharmaceutical Industries Ltd. (Israel)
    • 11.2.7. Sanofi (France)
    • 11.2.8. Boehringer Ingelheim International GmbH. (Germany)
    • 11.2.9. AstraZeneca (U.K.)
    • 11.2.10. Johnson & Johnson Private Limited (U.S.)

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
  • 12.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Cough Hypersensitivity Syndrome Market, report scope
  • TABLE 2. Global Cough Hypersensitivity Syndrome Market estimates & forecasts by Region 2018-2028 (USD Million)
  • TABLE 3. Global Cough Hypersensitivity Syndrome Market estimates & forecasts by Drug Class 2018-2028 (USD Million)
  • TABLE 4. Global Cough Hypersensitivity Syndrome Market estimates & forecasts by Route of Administration 2018-2028 (USD Million)
  • TABLE 5. Global Cough Hypersensitivity Syndrome Market estimates & forecasts by End Users 2018-2028 (USD Million)
  • TABLE 6. Global Cough Hypersensitivity Syndrome Market estimates & forecasts by Distribution Channel 2018-2028 (USD Million)
  • TABLE 7. Global Cough Hypersensitivity Syndrome Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 8. Global Cough Hypersensitivity Syndrome Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 9. Global Cough Hypersensitivity Syndrome Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 10. Global Cough Hypersensitivity Syndrome Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 11. Global Cough Hypersensitivity Syndrome Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 12. Global Cough Hypersensitivity Syndrome Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 13. Global Cough Hypersensitivity Syndrome Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 14. Global Cough Hypersensitivity Syndrome Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 15. Global Cough Hypersensitivity Syndrome Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 16. Global Cough Hypersensitivity Syndrome Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 17. U.S. Cough Hypersensitivity Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 18. U.S. Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 19. U.S. Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 20. Canada Cough Hypersensitivity Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 21. Canada Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 22. Canada Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 23. UK Cough Hypersensitivity Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 24. UK Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 25. UK Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 26. Germany Cough Hypersensitivity Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 27. Germany Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 28. Germany Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 29. RoE Cough Hypersensitivity Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 30. RoE Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 31. RoE Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 32. China Cough Hypersensitivity Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 33. China Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 34. China Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 35. India Cough Hypersensitivity Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 36. India Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 37. India Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 38. Japan Cough Hypersensitivity Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 39. Japan Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 40. Japan Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 41. RoAPAC Cough Hypersensitivity Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 42. RoAPAC Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 43. RoAPAC Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 44. Brazil Cough Hypersensitivity Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 45. Brazil Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 46. Brazil Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 47. Mexico Cough Hypersensitivity Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 48. Mexico Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 49. Mexico Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 50. RoLA Cough Hypersensitivity Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 51. RoLA Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 52. RoLA Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 53. Row Cough Hypersensitivity Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 54. Row Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 55. Row Cough Hypersensitivity Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 56. List of secondary sources, used in the study of global Cough Hypersensitivity Syndrome Market
  • TABLE 57. List of primary sources, used in the study of global Cough Hypersensitivity Syndrome Market
  • TABLE 58. Years considered for the study
  • TABLE 59. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Cough Hypersensitivity Syndrome Market, research methodology
  • FIG 2. Global Cough Hypersensitivity Syndrome Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Cough Hypersensitivity Syndrome Market, key trends 2021
  • FIG 5. Global Cough Hypersensitivity Syndrome Market, growth prospects 2022-2028
  • FIG 6. Global Cough Hypersensitivity Syndrome Market, porters 5 force model
  • FIG 7. Global Cough Hypersensitivity Syndrome Market, pest analysis
  • FIG 8. Global Cough Hypersensitivity Syndrome Market, value chain analysis
  • FIG 9. Global Cough Hypersensitivity Syndrome Market by segment, 2018 & 2028 (USD Million)
  • FIG 10. Global Cough Hypersensitivity Syndrome Market by segment, 2018 & 2028 (USD Million)
  • FIG 11. Global Cough Hypersensitivity Syndrome Market by segment, 2018 & 2028 (USD Million)
  • FIG 12. Global Cough Hypersensitivity Syndrome Market by segment, 2018 & 2028 (USD Million)
  • FIG 13. Global Cough Hypersensitivity Syndrome Market by segment, 2018 & 2028 (USD Million)
  • FIG 14. Global Cough Hypersensitivity Syndrome Market, regional snapshot 2018 & 2028
  • FIG 15. North America Cough Hypersensitivity Syndrome Market 2018 & 2028 (USD Million)
  • FIG 16. Europe Cough Hypersensitivity Syndrome Market 2018 & 2028 (USD Million)
  • FIG 17. Asia pacific Market 2018 & 2028 (USD Million)
  • FIG 18. Latin America Cough Hypersensitivity Syndrome Market 2018 & 2028 (USD Million)
  • FIG 19. Global Cough Hypersensitivity Syndrome Market, company Market share analysis (2021)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!